Lifecore Biomedical CEO Resigns; Intergel Withdrawal Review Continues
This article was originally published in The Gray Sheet
Executive Summary
Dennis Allingham's replacement of former Lifecore Biomedical President & CEO James Bracke comes amid an ongoing review of reported adverse events related to the firm's Intergel adhesion barrier